908 Devices Inc. MASS

BURLINGTON, Mass., September 01, 2026--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, announced it will participate in the upcoming 32nd Annual Gabelli Aerospace & Defense Symposium on September 10, 2026, in New York City.

908 Devices Inc (MASS) delivered 23% revenue growth in Q2 2026, driven by robust demand and strategic acquisitions, while improving profitability and raising full-year guidance.

BURLINGTON, Mass., August 12, 2026--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, announced that CEO and Co-founder Kevin J. Knopp and CFO Joe Griffith will present and host investor meetings at the 17th Annual Midwest IDEAS Conference on Wednesday, August 26, 2026.

Moby summary of 908 Devices Inc.'s Q2 2026 earnings call

908 Devices (MASS) delivered earnings and revenue surprises of +21.43% and +5.92%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

BURLINGTON, Mass., August 11, 2026--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety, and defense tech applications, today reported financial results for the quarter ended June 30, 2026.

Rapid Micro Biosystems (RPID) delivered earnings and revenue surprises of -3.85% and +3.26%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

908 Devices (MASS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BURLINGTON, Mass., July 29, 2026--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, announced it will participate in the upcoming Canaccord Genuity 46th Annual Growth Conference.

BURLINGTON, Mass., July 28, 2026--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, announced it will report financial results for the second quarter 2026 before market open on Tuesday, August 11, 2026. Company management will webcast a corresponding conference call beginning at 8:30 a.m. Eastern Time.

The global mobile mass spectrometers market is set to grow from USD 1.68 billion in 2026 to USD 2.87 billion by 2031, at a CAGR of 11.3%. This significant growth is driven by the demand for real-time, on-site chemical analysis in diverse industries such as environmental monitoring and defense. Ion sources top market components, with their pivotal role in sampling and analysis. Field-deployable platforms lead the product segment, offering portability essential for immediate results. North America